Symbol
| ICOSLG
| contributors: mct - updated : 02-01-2017
|
HGNC name
| inducible T-cell co-stimulator ligand
|
HGNC id
| 17087
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in patients with systemic lupus erythematosus | constitutional
|  
|  
| --over
|  
|
of ICOS and ICOSLG in Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and vasculitic neuropathy (VN) vs patients with hereditary neuropathies (HNs) | |
Susceptibility
|
to Crohn disease |
Variant & Polymorphism
other
| rs7282490 ICOSLG GG risk carriers associated with an ileal Crohn disease phenotype |
|
|
Candidate gene
Marker
Therapy target
| | | |
| Icosl -/- mice are healthy and fertile but have a reduced IgG1 production and affinity maturation, indicating a defect in T cell responses. Also have impaired T and B-cell interaction and germinal center formation |